# Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.

> **NCT01123434** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 200 (estimated)

## Conditions studied

- 2 Years PSA Recurrence Rate

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01123434
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2015-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01123434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01123434, "Immediate Postoperative Adjuvant Hormonal Treatment in High Risk Localised or Locally Advanced Prostate Cancer Patients.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01123434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*